Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application symbols : Amgn save search
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published: 2023-12-13 (Crawled : 21:00) - prnewswire.com
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 0.91%
H: 2.03%
C: 1.4%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
fda lung review cancer cell application grants advanced
AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING
Published: 2023-08-21 (Crawled : 20:00) - prnewswire.com
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: -0.27%
H: 0.99%
C: -0.67%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.18%
H: 0.06%
C: -1.01%
lumakras fda treatment meeting application
Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA
Published: 2023-02-06 (Crawled : 07:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: -2.93%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.33%
H: 0.15%
C: -0.12%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.08%
H: 0.59%
C: -0.62%
fda biosimilar application license
Recombinant Proteins Market Size worth USD 633.23 Mn by 2026, Market Analysis Segmented by Application and Geography - Technavio
Published: 2022-09-12 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.72%
H: 0.07%
C: -1.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.97%
H: 0.16%
C: -0.98%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
ABCM | News | $23.99 0.0% 7.4M
|
Health Technology
|
| O: 0.06%
H: 0.83%
C: 0.06%
application market
Renal Anemia Therapeutics Market Segmented by Application and Geography, Region, Size, Outlook, Share and Forecast 2022-2026 | Technavio
Published: 2022-05-18 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -2.66%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.92%
H: 0.5%
C: -1.4%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.93%
H: 0.32%
C: -1.03%
application renal anemia therapeutics market
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $558.779 -19.1% 23
|
Health Technology
|
| O: -1.72%
H: 0.46%
C: -0.51%
LZAGY | $57.57 0.02% 93K
|
Professional, Scientific, and T...
|
| O: -1.31%
H: 2.63%
C: 0.75%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
covid-19 application covid services growing
Bristol Myers Squibb’s Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -1.18%
H: 1.16%
C: 0.49%
psoriasis food treatment europe application drug plague
Biosimilars Market by Application and Geography | Global Forecast to 2025 | 17,000+ Technavio Research Reports
Published: 2021-09-22 (Crawled : 00:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.38%
H: 1.5%
C: 0.3%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.53%
H: 1.43%
C: 1.2%
research application biosimilar
Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA
Published: 2021-05-10 (Crawled : 16:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: -0.63%
H: 0.95%
C: -2.15%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.38%
H: 0.27%
C: -0.31%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.7%
H: 1.1%
C: -1.32%
fda license application
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: -0.5%
H: 3.2%
C: -1.07%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.43%
H: 1.5%
C: 1.24%
new drug fda drug psoriasis fda acceptance application plague
Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis
Published: 2021-02-22 (Crawled : 14:12) - prnewswire.com
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.59%
H: 1.51%
C: 0.49%
drug new drug psoriasis application plague
Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation
Published: 2020-12-16 (Crawled : 21:11) - prnewswire.com
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.3%
H: 0.99%
C: 0.93%
fda cancer drug lung cancer new drug application
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.